Moreover, Schneider Capital Management Corp has 6.86% invested in the company for 3.27 million shares. The company has a market capitalization of $23.77 billion, a price-to-earnings ratio of 73.06 and a beta of 0.99. The stock price volatility for last week at the close of regular trading was 2.83%, pushing the figure for the whole month to now reaching 4.12%. 1,426,904 shares of the company traded hands, compared to its average volume of 1,770,853.
Concho Resources (NYSE:CXO) has insider ownership of 1.10% and institutional ownership of 95.16%. The stock outperformed the S&P 500 by 13.85%.
Segantii Capital Management Ltd increased China Unicom (Hong Kong) Ltd (CHU) stake by 12.21% reported in 2017Q4 SEC filing. Accern also gave news headlines about the oil and natural gas company an impact score of 45.9133600764917 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days. Ami Asset holds 1.06% or 101,949 shares. The stock increased 0.59% or $0.08 during the last trading session, reaching $14. About 3.13M shares traded or 54.08% up from the average. TerraForm Power, Inc. (NASDAQ:TERP) has risen 5.90% since May 14, 2017 and is uptrending. It has underperformed by 11.55% the S&P500. During the same quarter in the prior year, the company posted $0.20 EPS. equities research analysts anticipate that Concho Resources will post 3.72 EPS for the current year. Jefferies Group set a $185.00 price target on Concho Resources and gave the company a "buy" rating in a research report on Tuesday, January 30th. Therefore 62% are positive. 71% are bullish. 34 are the (NYSE:CXO)'s analyst reports since November 20, 2017 according to StockzIntelligence Inc. (NYSE:CXO) rating. BMO Capital Markets has "Buy" rating and $200.0 target. On Monday, April 16 SunTrust maintained the shares of CXO in report with "Hold" rating. The rating was maintained by Williams Capital Group with "Buy" on Thursday, April 26. As per Thursday, March 29, the company rating was maintained by Jefferies. The rating was maintained by RBC Capital Markets with "Buy" on Wednesday, December 20. On Tuesday, January 30 the firm has "Buy" rating by Jefferies given. Listed here are Concho Resources Inc. (NYSE:CXO) on Monday, September 18 with "Overweight" rating. The rating was downgraded by KLR Group to "Hold" on Thursday, December 21.
Since January 1, 0001, it had 0 insider purchases, and 1 insider sale for $603,480 activity.
Investors sentiment increased to 1.41 in Q4 2017. Its down -0.20, from 1.23 in 2017Q3. 74 funds took holdings and 142 increased holdings. Investors holded 137.75 million in 2017Q3 but now own 140.14 million shares or 1.74% more. Manufacturers Life Insurance The holds 161,987 shares or 0.03% of its portfolio. Gateway Investment Advisers Ltd Company stated it has 155,392 shares or 0.2% of all its holdings. Morgan Stanley holds 136,167 shares.
Concho Resources (NYSE:CXO) last released its quarterly earnings data on Tuesday, May 1st. (NYSE:CXO). State Of Wisconsin Invest Board accumulated 258,178 shs. Cadence Cap Mngmt Limited Liability Company invested 0.05% of its portfolio in Concho Resources Inc. (NYSE:CXO) PTs and latest ratings. Gabelli Funds Lc owns 0.03% invested in Concho Resources Inc. (NYSE:CXO) on Tuesday, January 2. Exane Derivatives reported 0.01% in Concho Resources Inc. (NYSE:CXO). 44,523 are held by Apg Asset Mngmt Nv. The Texas-based Texas Capital Bancshares Inc Tx has invested 2.44% in the stock. Ameriprise holds 0.02% or 341,086 shares. Concho Resources had a net margin of 39.06% and a return on equity of 4.34%. (NYSE:CXO) news were brought out by Seekingalpha.com, Seekingalpha.com and Seekingalpha.com. The first one has "US Shale: NAV Analysis Of Eagle Ford Shale E&Ps" as a title and was announced on May 08, 2018. The next is "Devon Energy's big wells could boost Permian peers, analyst says" on May 03, 2018. On Wednesday, April 11 BMO Capital Markets maintained Concho Resources Inc. It also reduced its holding in Sage Therapeutics Inc (Call) (NASDAQ:SAGE) by 59,000 shares in the quarter, leaving it with 100,000 shares, and cut its stake in Cidara Therapeutics Inc.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.